Evidence map›Paper›PMID 41909811›Full record

ArticleFrontiers in bioinformatics2026

Population HLA coverage of experimentally characterized

Courage Siame, Rafiatu Abdul-Mumin, Georgina Agyekum, Linda Akuffo, Ernest Afari, Cecilia Adwoa Biaa Yankey, Kwadwo Asamoah Kusi

Abstract read
In one paragraph

Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Courage SiameDepartment of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
Rafiatu Abdul-MuminDepartment of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
Georgina AgyekumDepartment of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
Linda AkuffoDepartment of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
Ernest AfariDepartment of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
Cecilia Adwoa Biaa YankeyDepartment of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
Kwadwo Asamoah KusiDepartment of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Malaria remains a significant global health challenge, with Methodology: Sixteen experimentally validated CD8 Result: CSPep1, CSPep2, CSPep4, CSPep6, CSPep9, CSPep10, CSPep11, and TRAPep1 were 100% conserved across the sixteen strains of Conclusion: These findings highlight the importance of integrating host HLA binding promiscuity and parasite epitope conservation in developing universal or pan multi-epitope malaria vaccines. By combining conserved epitopes with broad HLA coverage, this approach promotes wide immune recognition while limiting strain-specific immune evasion. Incorporating relevant HLA class II and antibody epitopes could further enhance immune responses, providing effective protection for both children in malaria-endemic regions and malaria-naïve travelers.

Indexed as

epitope predictionHLAimmune epitope databasemalariaP. falciparum

Identifiers

PMID41909811
PMCPMC13018126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.